Enhanced dendritic cell percentages and activation and decreased IL-10 expressing dendritic cells after agonistic anti-TIGIT treatment. by Amanda C. Foks (302836)

Incubation of <i>T</i>. <i>brucei</i> with Pol I transcription inhibitors results in a dramatic decrease in VEX1 foci. by Louise E. Kerry (3815164)

Effect of VEGF121 or VEGF165 on TEER in SCE cell monolayers. by Tomokazu Fujimoto (709192)

Tau phosphorylation is decreased in neurons treated with 20 mM KCl. by Nguyen-Vi Mohamed (323606)

The minimal data set 10. by Esete Habtemariam Fenta (9727779)

PB2 variants D605A and V606A do not affect the secondary structures of the PB2 ‘627’ domain. by Ho-Pan Hsia (4768638)

Decreased processivity of A3G NPM was attributable to changes in sliding, but not jumping movements. by Anjuman Ara (540372)

The loss of Sad kinases leads to a decrease in the number of neuronal progenitors in the cortex. by Pratibha Dhumale (5146484)

Pretreatment with Y-26732 Decreased Caspase-3 Activity in CSCs Induced by Dox. by Lijuan Kan (834976)

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 8 by Jin Zhou (90734)

JS-10 phantom. by Masakazu Tsujimoto (22339504)

“…At ≥50 s/view, variation in the maximum and mean SUVs decreased, with the RSE remaining below 5%. In conclusion, accurate SUV measurement with ¹²³I-MIBG requires an acquisition time of ≥50 s/view, an SI product of approximately 120, and a Gaussian filter of 10 − 12 mm. …”

The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

“…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 4 by Jin Zhou (90734)

The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

Knocking down of TRIM59 decreased the expression of cell cycle proteins. by Weihua Zhan (830500)

Loss of <i>SLC4A11</i> expression in hCEnC leads to decreased cell barrier function. by Doug D. Chung (3611387)

The association between CMI and testosterone deficiency. by Xuanchun Huang (17359851)

The association between CMI and testosterone level. by Xuanchun Huang (17359851)

Kaplan-Meier survival curves demonstrated 28-day survival rates in SFTS patients with HLH based on varying levels of (A) age, (B) FIB, and (C) PCT. by Bo Zhang (6559)

Stroma decreases spheroid size by decreasing cell width. by Karen F. Chambers (224337)